Impact of cytomegalovirus serologic status on heart transplantation.

Alejandro Suarez-PierreKatherine GiulianoCecillia LuiDaniel AlmaguerEric EtchillChun W ChoiAhmet KilicRobert S Higgins

Published in: Journal of cardiac surgery (2020)

CMV seropositivity at the time of transplantation is associated with increased long-term risk of mortality. Chemoprophylaxis with antivirals seems to mitigate this risk. There was no association with an increased risk of allograft vasculopathy.

Keyphrases

cardiovascular events
epstein barr virus
risk factors
cell therapy
kidney transplantation
stem cells
cardiovascular disease
respiratory syndrome coronavirus
type diabetes
mesenchymal stem cells